Product Details
| Cat # +Size | A1737-100 |
|---|---|
| Size | 100 µl |
| Antibody Target | Extracellular signal regulated kinase 8 |
| Alternate Name | ERK-7, ERK-8, ERK7, ERK8, Extracellular regulated kinase 8 delta, Extracellular signal regulated kinase 8, Extracellular signal-regulated kinase 7, Extracellular signal-regulated kinase 8, MAP kinase 15, MAPK 15, Mapk15, Mitogen activated protein kinase 15, Mitogen-activated protein kinase 15, MK15_HUMAN |
| Host | Rabbit |
| Antibody Type | Polyclonal |
| Isotype | IgG |
| Accession # | Q8TD08 |
| Gene ID | 225689 |
| Appearance | Colorless liquid |
| Concentration | 1mg/ml |
| Formulation | In phosphate buffered saline pH 7.4 150mM NaCl 0.02% sodium azide and 50% glycerol. |
| Purification | Affinity purification |
| Species Reactivity | Mouse, Human |
| Application | Immunofluorescence (IF), Immunocytochemistry (ICC), Western Blotting, ELISA |
| Application & Usage | WB 1:500-1:2000 IF/ICC 1:100-1:500 ELISA(peptide) 1:20000-1:40000 |
| Handling | The antibody solution should be gently mixed before use. |
| Storage Conditions | -20ºC |
| Shipping Conditions | Gel Pack |
| USAGE | For Research Use Only! Not For Use in Humans. |
Details
ERK7 is phosphorylates MBP in vitro. Interacts with CSK/cSrc ABL1 and RET. 3 isoforms of the human protein are produced by alternative splicing.
Why buy BioVision Products?
 |
 |
 |
 |
Innovation |
Affordability |
Global Presence |
Technical Support |
BioVision aims to provide our customers innovative tools for accelerating drug discovery and biological research. BioVision offers >8,000 products including the most comprehensive array of assay kits for key targets in Metabolic pathways. |
BioVision is committed to providing the highest quality products at a competitive price. |
We have a broad network of global distributors who are ready to address your research needs and ensure fast delivery. |
Our highly trained Technical Support team provides comprehensive product support and is dedicated to resolving your issues quickly and efficiently. |
